ExThera Blood-Infection Filter Will Get 'Expedited Access' From US FDA
Executive Summary
The firm's Seraph 100 blood filter leverages proprietary receptor technology to capture and remove drug-resistant infections and return the blood to the patient with cells intact. FDA says it's a novel enough approach to infections suffered by dialysis patients to be accepted into the Expedited Access Pathway.